Inhibition of the vagal component of the baroreceptor-cardioinhibitory reflex by angiotensin III in dogs and sheep.
Angiotensin II inhibits baroreceptor-evoked activity in cardiac vagal motoneurones. Because angiotensin III [( des-1-Asp ]angiotensin II) is a less potent pressor agent than angiotensin II, and has been reported not to share some of the actions of angiotensin II within the central nervous system, its influence on central vagal pathways was examined here. In unanaesthetized sheep equipressor doses of angiotensins II and III similarly inhibited the baroreceptor-cardioinhibitory reflex, a reflex which is almost wholly dependent on cardiac vagal activity. In anaesthetized dogs, equipressor doses of angiotensin II and III were equally effective in inhibiting the cardiac vagal activity usually evoked by rises in arterial pressure. This was established by direct recordings of activity in single cardiac vagal efferent nerve fibres. Direct recordings from single baroreceptor nerves in anaesthetized dogs showed that the angiotensins do not depress the receptor responses to elevations in blood pressure. It is concluded that equipressor doses of angiotensin III and angiotensin II inhibit central vagal pathways to the same extent.
D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000494:pharmacology; D000805:Angiotensin III / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D006321:Heart / Q000294:innervation*; D009476:Neurons, Efferent / Q000187:drug effects; D010656:Phenylephrine / Q000494:pharmacology; D011311:Pressoreceptors / Q000187:drug effects*; D011674:Pulse / Q000187:drug effects; D012018:Reflex / Q000187:drug effects*; D012756:Sheep; D014630:Vagus Nerve / Q000187:drug effects*
D000804:Angiotensin II; D000805:Angiotensin III; D010656:Phenylephrine